[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Growth (Status and Outlook) 2023-2029

March 2023 | 120 pages | ID: G350416B0265EN
LP Information

US$ 3,660.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The report requires updating with new data and is sent in 48 hours after order is placed.

The global Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.

United States market for Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

China market for Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Europe market for Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Global key Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) players cover Lonza, Catalent, Patheon (Thermo Fisher Scientific), Aenova, Siegfried, Recipharm, Strides Shasun, Piramal and Metrics, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.

LPI (LP Information)' newest research report, the “Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Industry Forecast” looks at past sales and reviews total world Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) sales in 2022, providing a comprehensive analysis by region and market sector of projected Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) sales for 2023 through 2029. With Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) industry.

This Insight Report provides a comprehensive analysis of the global Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization).

This report presents a comprehensive overview, market shares, and growth opportunities of Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) market by product type, application, key players and key regions and countries.

Market Segmentation:

Segmentation by type
  • Intermediate CDMO
  • API CDMO
  • Formulation CDMO
  • Protein CDMO
  • Gene Therapy CDMO
  • Cell Therapy CDMO
Segmentation by application
  • Pharmaceutical Company
  • Biotechnology Company
  • Generic Company
  • Others
This report also splits the market by region:
  • Americas
    • United States
    • Canada
    • Mexico
    • Brazil
  • APAC
    • China
    • Japan
    • Korea
    • Southeast Asia
    • India
    • Australia
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Russia
  • Middle East & Africa
    • Egypt
    • South Africa
    • Israel
    • Turkey
    • GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
  • Lonza
  • Catalent
  • Patheon (Thermo Fisher Scientific)
  • Aenova
  • Siegfried
  • Recipharm
  • Strides Shasun
  • Piramal
  • Metrics
  • AMRI
  • Famar
  • WuXi AppTech
  • Asymchem
  • Porton
  • Amatsigroup
  • AcuraBio
  • Moravek
  • Ascendia Pharmaceuticals
  • Ardena
  • CPL
  • Arranta Bio
  • UPM Pharmaceuticals
  • FUJIFILM Diosynth Biotechnologies
  • Groupe Parima
  • TBD Pharmatech
  • Avid Bioservices
  • Vetter Pharma
  • NextPharma
  • Alcami
  • NerPharMa
  • Vetio
  • Societal CDMO
  • ten23 health
  • Piramal Pharma Solutions
  • MedPharm
  • Lundbeck
  • AGC Pharma Chemicals
  • BioVectra
  • Pfizer CentreOne
  • Jubilant Biosys
  • SEIKAGAKU CORPORATION
  • Mikart
  • Adare Pharma Solutions
  • Fermion
  • Samsung Biologics
  • Siegfried Holdings
  • Boehringer Ingelheim
  • Jubilant Pharmova Limited
  • Fareva SA
1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size 2018-2029
  2.1.2 Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size CAGR by Region 2018 VS 2022 VS 2029
2.2 Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Segment by Type
  2.2.1 Intermediate CDMO
  2.2.2 API CDMO
  2.2.3 Formulation CDMO
  2.2.4 Protein CDMO
  2.2.5 Gene Therapy CDMO
  2.2.6 Cell Therapy CDMO
2.3 Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size by Type
  2.3.1 Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size CAGR by Type (2018 VS 2022 VS 2029)
  2.3.2 Global Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size Market Share by Type (2018-2023)
2.4 Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Segment by Application
  2.4.1 Pharmaceutical Company
  2.4.2 Biotechnology Company
  2.4.3 Generic Company
  2.4.4 Others
2.5 Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size by Application
  2.5.1 Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size CAGR by Application (2018 VS 2022 VS 2029)
  2.5.2 Global Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size Market Share by Application (2018-2023)

3 PHARMACEUTICAL CDMO (PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING ORGANIZATION) MARKET SIZE BY PLAYER

3.1 Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size Market Share by Players
  3.1.1 Global Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue by Players (2018-2023)
  3.1.2 Global Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue Market Share by Players (2018-2023)
3.2 Global Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 PHARMACEUTICAL CDMO (PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING ORGANIZATION) BY REGIONS

4.1 Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size by Regions (2018-2023)
4.2 Americas Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size Growth (2018-2023)
4.3 APAC Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size Growth (2018-2023)
4.4 Europe Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size Growth (2018-2023)
4.5 Middle East & Africa Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size Growth (2018-2023)

5 AMERICAS

5.1 Americas Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size by Country (2018-2023)
5.2 Americas Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size by Type (2018-2023)
5.3 Americas Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size by Application (2018-2023)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size by Region (2018-2023)
6.2 APAC Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size by Type (2018-2023)
6.3 APAC Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size by Application (2018-2023)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 EUROPE

7.1 Europe Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) by Country (2018-2023)
7.2 Europe Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size by Type (2018-2023)
7.3 Europe Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size by Application (2018-2023)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) by Region (2018-2023)
8.2 Middle East & Africa Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size by Type (2018-2023)
8.3 Middle East & Africa Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size by Application (2018-2023)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 GLOBAL PHARMACEUTICAL CDMO (PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING ORGANIZATION) MARKET FORECAST

10.1 Global Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Forecast by Regions (2024-2029)
  10.1.1 Global Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Forecast by Regions (2024-2029)
  10.1.2 Americas Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Forecast
  10.1.3 APAC Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Forecast
  10.1.4 Europe Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Forecast
  10.1.5 Middle East & Africa Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Forecast
10.2 Americas Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Forecast by Country (2024-2029)
  10.2.1 United States Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Forecast
  10.2.2 Canada Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Forecast
  10.2.3 Mexico Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Forecast
  10.2.4 Brazil Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Forecast
10.3 APAC Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Forecast by Region (2024-2029)
  10.3.1 China Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Forecast
  10.3.2 Japan Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Forecast
  10.3.3 Korea Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Forecast
  10.3.4 Southeast Asia Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Forecast
  10.3.5 India Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Forecast
  10.3.6 Australia Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Forecast
10.4 Europe Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Forecast by Country (2024-2029)
  10.4.1 Germany Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Forecast
  10.4.2 France Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Forecast
  10.4.3 UK Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Forecast
  10.4.4 Italy Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Forecast
  10.4.5 Russia Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Forecast
10.5 Middle East & Africa Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Forecast by Region (2024-2029)
  10.5.1 Egypt Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Forecast
  10.5.2 South Africa Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Forecast
  10.5.3 Israel Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Forecast
  10.5.4 Turkey Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Forecast
  10.5.5 GCC Countries Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Forecast
10.6 Global Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Forecast by Type (2024-2029)
10.7 Global Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Forecast by Application (2024-2029)

11 KEY PLAYERS ANALYSIS

11.1 Lonza
  11.1.1 Lonza Company Information
  11.1.2 Lonza Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product Offered
  11.1.3 Lonza Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue, Gross Margin and Market Share (2018-2023)
  11.1.4 Lonza Main Business Overview
  11.1.5 Lonza Latest Developments
11.2 Catalent
  11.2.1 Catalent Company Information
  11.2.2 Catalent Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product Offered
  11.2.3 Catalent Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue, Gross Margin and Market Share (2018-2023)
  11.2.4 Catalent Main Business Overview
  11.2.5 Catalent Latest Developments
11.3 Patheon (Thermo Fisher Scientific)
  11.3.1 Patheon (Thermo Fisher Scientific) Company Information
  11.3.2 Patheon (Thermo Fisher Scientific) Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product Offered
  11.3.3 Patheon (Thermo Fisher Scientific) Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue, Gross Margin and Market Share (2018-2023)
  11.3.4 Patheon (Thermo Fisher Scientific) Main Business Overview
  11.3.5 Patheon (Thermo Fisher Scientific) Latest Developments
11.4 Aenova
  11.4.1 Aenova Company Information
  11.4.2 Aenova Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product Offered
  11.4.3 Aenova Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue, Gross Margin and Market Share (2018-2023)
  11.4.4 Aenova Main Business Overview
  11.4.5 Aenova Latest Developments
11.5 Siegfried
  11.5.1 Siegfried Company Information
  11.5.2 Siegfried Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product Offered
  11.5.3 Siegfried Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue, Gross Margin and Market Share (2018-2023)
  11.5.4 Siegfried Main Business Overview
  11.5.5 Siegfried Latest Developments
11.6 Recipharm
  11.6.1 Recipharm Company Information
  11.6.2 Recipharm Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product Offered
  11.6.3 Recipharm Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue, Gross Margin and Market Share (2018-2023)
  11.6.4 Recipharm Main Business Overview
  11.6.5 Recipharm Latest Developments
11.7 Strides Shasun
  11.7.1 Strides Shasun Company Information
  11.7.2 Strides Shasun Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product Offered
  11.7.3 Strides Shasun Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue, Gross Margin and Market Share (2018-2023)
  11.7.4 Strides Shasun Main Business Overview
  11.7.5 Strides Shasun Latest Developments
11.8 Piramal
  11.8.1 Piramal Company Information
  11.8.2 Piramal Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product Offered
  11.8.3 Piramal Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue, Gross Margin and Market Share (2018-2023)
  11.8.4 Piramal Main Business Overview
  11.8.5 Piramal Latest Developments
11.9 Metrics
  11.9.1 Metrics Company Information
  11.9.2 Metrics Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product Offered
  11.9.3 Metrics Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue, Gross Margin and Market Share (2018-2023)
  11.9.4 Metrics Main Business Overview
  11.9.5 Metrics Latest Developments
11.10 AMRI
  11.10.1 AMRI Company Information
  11.10.2 AMRI Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product Offered
  11.10.3 AMRI Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue, Gross Margin and Market Share (2018-2023)
  11.10.4 AMRI Main Business Overview
  11.10.5 AMRI Latest Developments
11.11 Famar
  11.11.1 Famar Company Information
  11.11.2 Famar Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product Offered
  11.11.3 Famar Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue, Gross Margin and Market Share (2018-2023)
  11.11.4 Famar Main Business Overview
  11.11.5 Famar Latest Developments
11.12 WuXi AppTech
  11.12.1 WuXi AppTech Company Information
  11.12.2 WuXi AppTech Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product Offered
  11.12.3 WuXi AppTech Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue, Gross Margin and Market Share (2018-2023)
  11.12.4 WuXi AppTech Main Business Overview
  11.12.5 WuXi AppTech Latest Developments
11.13 Asymchem
  11.13.1 Asymchem Company Information
  11.13.2 Asymchem Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product Offered
  11.13.3 Asymchem Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue, Gross Margin and Market Share (2018-2023)
  11.13.4 Asymchem Main Business Overview
  11.13.5 Asymchem Latest Developments
11.14 Porton
  11.14.1 Porton Company Information
  11.14.2 Porton Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product Offered
  11.14.3 Porton Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue, Gross Margin and Market Share (2018-2023)
  11.14.4 Porton Main Business Overview
  11.14.5 Porton Latest Developments
11.15 Amatsigroup
  11.15.1 Amatsigroup Company Information
  11.15.2 Amatsigroup Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product Offered
  11.15.3 Amatsigroup Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue, Gross Margin and Market Share (2018-2023)
  11.15.4 Amatsigroup Main Business Overview
  11.15.5 Amatsigroup Latest Developments
11.16 AcuraBio
  11.16.1 AcuraBio Company Information
  11.16.2 AcuraBio Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product Offered
  11.16.3 AcuraBio Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue, Gross Margin and Market Share (2018-2023)
  11.16.4 AcuraBio Main Business Overview
  11.16.5 AcuraBio Latest Developments
11.17 Moravek
  11.17.1 Moravek Company Information
  11.17.2 Moravek Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product Offered
  11.17.3 Moravek Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue, Gross Margin and Market Share (2018-2023)
  11.17.4 Moravek Main Business Overview
  11.17.5 Moravek Latest Developments
11.18 Ascendia Pharmaceuticals
  11.18.1 Ascendia Pharmaceuticals Company Information
  11.18.2 Ascendia Pharmaceuticals Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product Offered
  11.18.3 Ascendia Pharmaceuticals Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue, Gross Margin and Market Share (2018-2023)
  11.18.4 Ascendia Pharmaceuticals Main Business Overview
  11.18.5 Ascendia Pharmaceuticals Latest Developments
11.19 Ardena
  11.19.1 Ardena Company Information
  11.19.2 Ardena Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product Offered
  11.19.3 Ardena Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue, Gross Margin and Market Share (2018-2023)
  11.19.4 Ardena Main Business Overview
  11.19.5 Ardena Latest Developments
11.20 CPL
  11.20.1 CPL Company Information
  11.20.2 CPL Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product Offered
  11.20.3 CPL Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue, Gross Margin and Market Share (2018-2023)
  11.20.4 CPL Main Business Overview
  11.20.5 CPL Latest Developments
11.21 Arranta Bio
  11.21.1 Arranta Bio Company Information
  11.21.2 Arranta Bio Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product Offered
  11.21.3 Arranta Bio Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue, Gross Margin and Market Share (2018-2023)
  11.21.4 Arranta Bio Main Business Overview
  11.21.5 Arranta Bio Latest Developments
11.22 UPM Pharmaceuticals
  11.22.1 UPM Pharmaceuticals Company Information
  11.22.2 UPM Pharmaceuticals Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product Offered
  11.22.3 UPM Pharmaceuticals Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue, Gross Margin and Market Share (2018-2023)
  11.22.4 UPM Pharmaceuticals Main Business Overview
  11.22.5 UPM Pharmaceuticals Latest Developments
11.23 FUJIFILM Diosynth Biotechnologies
  11.23.1 FUJIFILM Diosynth Biotechnologies Company Information
  11.23.2 FUJIFILM Diosynth Biotechnologies Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product Offered
  11.23.3 FUJIFILM Diosynth Biotechnologies Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue, Gross Margin and Market Share (2018-2023)
  11.23.4 FUJIFILM Diosynth Biotechnologies Main Business Overview
  11.23.5 FUJIFILM Diosynth Biotechnologies Latest Developments
11.24 Groupe Parima
  11.24.1 Groupe Parima Company Information
  11.24.2 Groupe Parima Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product Offered
  11.24.3 Groupe Parima Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue, Gross Margin and Market Share (2018-2023)
  11.24.4 Groupe Parima Main Business Overview
  11.24.5 Groupe Parima Latest Developments
11.25 TBD Pharmatech
  11.25.1 TBD Pharmatech Company Information
  11.25.2 TBD Pharmatech Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product Offered
  11.25.3 TBD Pharmatech Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue, Gross Margin and Market Share (2018-2023)
  11.25.4 TBD Pharmatech Main Business Overview
  11.25.5 TBD Pharmatech Latest Developments
11.26 Avid Bioservices
  11.26.1 Avid Bioservices Company Information
  11.26.2 Avid Bioservices Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product Offered
  11.26.3 Avid Bioservices Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue, Gross Margin and Market Share (2018-2023)
  11.26.4 Avid Bioservices Main Business Overview
  11.26.5 Avid Bioservices Latest Developments
11.27 Vetter Pharma
  11.27.1 Vetter Pharma Company Information
  11.27.2 Vetter Pharma Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product Offered
  11.27.3 Vetter Pharma Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue, Gross Margin and Market Share (2018-2023)
  11.27.4 Vetter Pharma Main Business Overview
  11.27.5 Vetter Pharma Latest Developments
11.28 NextPharma
  11.28.1 NextPharma Company Information
  11.28.2 NextPharma Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product Offered
  11.28.3 NextPharma Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue, Gross Margin and Market Share (2018-2023)
  11.28.4 NextPharma Main Business Overview
  11.28.5 NextPharma Latest Developments
11.29 Alcami
  11.29.1 Alcami Company Information
  11.29.2 Alcami Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product Offered
  11.29.3 Alcami Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue, Gross Margin and Market Share (2018-2023)
  11.29.4 Alcami Main Business Overview
  11.29.5 Alcami Latest Developments
11.30 NerPharMa
  11.30.1 NerPharMa Company Information
  11.30.2 NerPharMa Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product Offered
  11.30.3 NerPharMa Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue, Gross Margin and Market Share (2018-2023)
  11.30.4 NerPharMa Main Business Overview
  11.30.5 NerPharMa Latest Developments
11.31 Vetio
  11.31.1 Vetio Company Information
  11.31.2 Vetio Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product Offered
  11.31.3 Vetio Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue, Gross Margin and Market Share (2018-2023)
  11.31.4 Vetio Main Business Overview
  11.31.5 Vetio Latest Developments
11.32 Societal CDMO
  11.32.1 Societal CDMO Company Information
  11.32.2 Societal CDMO Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product Offered
  11.32.3 Societal CDMO Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue, Gross Margin and Market Share (2018-2023)
  11.32.4 Societal CDMO Main Business Overview
  11.32.5 Societal CDMO Latest Developments
11.33 ten23 health
  11.33.1 ten23 health Company Information
  11.33.2 ten23 health Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product Offered
  11.33.3 ten23 health Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue, Gross Margin and Market Share (2018-2023)
  11.33.4 ten23 health Main Business Overview
  11.33.5 ten23 health Latest Developments
11.34 Piramal Pharma Solutions
  11.34.1 Piramal Pharma Solutions Company Information
  11.34.2 Piramal Pharma Solutions Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product Offered
  11.34.3 Piramal Pharma Solutions Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue, Gross Margin and Market Share (2018-2023)
  11.34.4 Piramal Pharma Solutions Main Business Overview
  11.34.5 Piramal Pharma Solutions Latest Developments
11.35 MedPharm
  11.35.1 MedPharm Company Information
  11.35.2 MedPharm Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product Offered
  11.35.3 MedPharm Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue, Gross Margin and Market Share (2018-2023)
  11.35.4 MedPharm Main Business Overview
  11.35.5 MedPharm Latest Developments
11.36 Lundbeck
  11.36.1 Lundbeck Company Information
  11.36.2 Lundbeck Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product Offered
  11.36.3 Lundbeck Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue, Gross Margin and Market Share (2018-2023)
  11.36.4 Lundbeck Main Business Overview
  11.36.5 Lundbeck Latest Developments
11.37 AGC Pharma Chemicals
  11.37.1 AGC Pharma Chemicals Company Information
  11.37.2 AGC Pharma Chemicals Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product Offered
  11.37.3 AGC Pharma Chemicals Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue, Gross Margin and Market Share (2018-2023)
  11.37.4 AGC Pharma Chemicals Main Business Overview
  11.37.5 AGC Pharma Chemicals Latest Developments
11.38 BioVectra
  11.38.1 BioVectra Company Information
  11.38.2 BioVectra Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product Offered
  11.38.3 BioVectra Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue, Gross Margin and Market Share (2018-2023)
  11.38.4 BioVectra Main Business Overview
  11.38.5 BioVectra Latest Developments
11.39 Pfizer CentreOne
  11.39.1 Pfizer CentreOne Company Information
  11.39.2 Pfizer CentreOne Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product Offered
  11.39.3 Pfizer CentreOne Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue, Gross Margin and Market Share (2018-2023)
  11.39.4 Pfizer CentreOne Main Business Overview
  11.39.5 Pfizer CentreOne Latest Developments
11.40 Jubilant Biosys
  11.40.1 Jubilant Biosys Company Information
  11.40.2 Jubilant Biosys Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product Offered
  11.40.3 Jubilant Biosys Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue, Gross Margin and Market Share (2018-2023)
  11.40.4 Jubilant Biosys Main Business Overview
  11.40.5 Jubilant Biosys Latest Developments
11.41 SEIKAGAKU CORPORATION
11.42 Mikart
11.43 Adare Pharma Solutions
11.44 Fermion
11.45 Samsung Biologics
11.46 Siegfried Holdings
11.47 Boehringer Ingelheim
11.48 Jubilant Pharmova Limited
11.49 Fareva SA

12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES

Table 1. Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size CAGR by Region (2018 VS 2022 VS 2029) & ($ Millions)
Table 2. Major Players of Intermediate CDMO
Table 3. Major Players of API CDMO
Table 4. Major Players of Formulation CDMO
Table 5. Major Players of Protein CDMO
Table 6. Major Players of Gene Therapy CDMO
Table 7. Major Players of Cell Therapy CDMO
Table 8. Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size CAGR by Type (2018 VS 2022 VS 2029) & ($ Millions)
Table 9. Global Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size by Type (2018-2023) & ($ Millions)
Table 10. Global Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size Market Share by Type (2018-2023)
Table 11. Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size CAGR by Application (2018 VS 2022 VS 2029) & ($ Millions)
Table 12. Global Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size by Application (2018-2023) & ($ Millions)
Table 13. Global Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size Market Share by Application (2018-2023)
Table 14. Global Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue by Players (2018-2023) & ($ Millions)
Table 15. Global Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue Market Share by Player (2018-2023)
Table 16. Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Key Players Head office and Products Offered
Table 17. Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
Table 18. New Products and Potential Entrants
Table 19. Mergers & Acquisitions, Expansion
Table 20. Global Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size by Regions 2018-2023 & ($ Millions)
Table 21. Global Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size Market Share by Regions (2018-2023)
Table 22. Global Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue by Country/Region (2018-2023) & ($ millions)
Table 23. Global Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue Market Share by Country/Region (2018-2023)
Table 24. Americas Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size by Country (2018-2023) & ($ Millions)
Table 25. Americas Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size Market Share by Country (2018-2023)
Table 26. Americas Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size by Type (2018-2023) & ($ Millions)
Table 27. Americas Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size Market Share by Type (2018-2023)
Table 28. Americas Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size by Application (2018-2023) & ($ Millions)
Table 29. Americas Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size Market Share by Application (2018-2023)
Table 30. APAC Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size by Region (2018-2023) & ($ Millions)
Table 31. APAC Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size Market Share by Region (2018-2023)
Table 32. APAC Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size by Type (2018-2023) & ($ Millions)
Table 33. APAC Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size Market Share by Type (2018-2023)
Table 34. APAC Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size by Application (2018-2023) & ($ Millions)
Table 35. APAC Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size Market Share by Application (2018-2023)
Table 36. Europe Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size by Country (2018-2023) & ($ Millions)
Table 37. Europe Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size Market Share by Country (2018-2023)
Table 38. Europe Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size by Type (2018-2023) & ($ Millions)
Table 39. Europe Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size Market Share by Type (2018-2023)
Table 40. Europe Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size by Application (2018-2023) & ($ Millions)
Table 41. Europe Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size Market Share by Application (2018-2023)
Table 42. Middle East & Africa Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size by Region (2018-2023) & ($ Millions)
Table 43. Middle East & Africa Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size Market Share by Region (2018-2023)
Table 44. Middle East & Africa Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size by Type (2018-2023) & ($ Millions)
Table 45. Middle East & Africa Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size Market Share by Type (2018-2023)
Table 46. Middle East & Africa Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size by Application (2018-2023) & ($ Millions)
Table 47. Middle East & Africa Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size Market Share by Application (2018-2023)
Table 48. Key Market Drivers & Growth Opportunities of Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization)
Table 49. Key Market Challenges & Risks of Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization)
Table 50. Key Industry Trends of Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization)
Table 51. Global Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size Forecast by Regions (2024-2029) & ($ Millions)
Table 52. Global Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size Market Share Forecast by Regions (2024-2029)
Table 53. Global Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size Forecast by Type (2024-2029) & ($ Millions)
Table 54. Global Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size Forecast by Application (2024-2029) & ($ Millions)
Table 55. Lonza Details, Company Type, Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Area Served and Its Competitors
Table 56. Lonza Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product Offered
Table 57. Lonza Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 58. Lonza Main Business
Table 59. Lonza Latest Developments
Table 60. Catalent Details, Company Type, Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Area Served and Its Competitors
Table 61. Catalent Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product Offered
Table 62. Catalent Main Business
Table 63. Catalent Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 64. Catalent Latest Developments
Table 65. Patheon (Thermo Fisher Scientific) Details, Company Type, Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Area Served and Its Competitors
Table 66. Patheon (Thermo Fisher Scientific) Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product Offered
Table 67. Patheon (Thermo Fisher Scientific) Main Business
Table 68. Patheon (Thermo Fisher Scientific) Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 69. Patheon (Thermo Fisher Scientific) Latest Developments
Table 70. Aenova Details, Company Type, Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Area Served and Its Competitors
Table 71. Aenova Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product Offered
Table 72. Aenova Main Business
Table 73. Aenova Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 74. Aenova Latest Developments
Table 75. Siegfried Details, Company Type, Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Area Served and Its Competitors
Table 76. Siegfried Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product Offered
Table 77. Siegfried Main Business
Table 78. Siegfried Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 79. Siegfried Latest Developments
Table 80. Recipharm Details, Company Type, Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Area Served and Its Competitors
Table 81. Recipharm Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product Offered
Table 82. Recipharm Main Business
Table 83. Recipharm Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 84. Recipharm Latest Developments
Table 85. Strides Shasun Details, Company Type, Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Area Served and Its Competitors
Table 86. Strides Shasun Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product Offered
Table 87. Strides Shasun Main Business
Table 88. Strides Shasun Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 89. Strides Shasun Latest Developments
Table 90. Piramal Details, Company Type, Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Area Served and Its Competitors
Table 91. Piramal Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product Offered
Table 92. Piramal Main Business
Table 93. Piramal Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 94. Piramal Latest Developments
Table 95. Metrics Details, Company Type, Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Area Served and Its Competitors
Table 96. Metrics Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product Offered
Table 97. Metrics Main Business
Table 98. Metrics Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 99. Metrics Latest Developments
Table 100. AMRI Details, Company Type, Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Area Served and Its Competitors
Table 101. AMRI Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product Offered
Table 102. AMRI Main Business
Table 103. AMRI Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 104. AMRI Latest Developments
Table 105. Famar Details, Company Type, Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Area Served and Its Competitors
Table 106. Famar Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product Offered
Table 107. Famar Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 108. Famar Main Business
Table 109. Famar Latest Developments
Table 110. WuXi AppTech Details, Company Type, Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Area Served and Its Competitors
Table 111. WuXi AppTech Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product Offered
Table 112. WuXi AppTech Main Business
Table 113. WuXi AppTech Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 114. WuXi AppTech Latest Developments
Table 115. Asymchem Details, Company Type, Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Area Served and Its Competitors
Table 116. Asymchem Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product Offered
Table 117. Asymchem Main Business
Table 118. Asymchem Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 119. Asymchem Latest Developments
Table 120. Porton Details, Company Type, Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Area Served and Its Competitors
Table 121. Porton Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product Offered
Table 122. Porton Main Business
Table 123. Porton Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 124. Porton Latest Developments
Table 125. Amatsigroup Details, Company Type, Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Area Served and Its Competitors
Table 126. Amatsigroup Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product Offered
Table 127. Amatsigroup Main Business
Table 128. Amatsigroup Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 129. Amatsigroup Latest Developments
Table 130. AcuraBio Details, Company Type, Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Area Served and Its Competitors
Table 131. AcuraBio Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product Offered
Table 132. AcuraBio Main Business
Table 133. AcuraBio Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 134. AcuraBio Latest Developments
Table 135. Moravek Details, Company Type, Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Area Served and Its Competitors
Table 136. Moravek Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product Offered
Table 137. Moravek Main Business
Table 138. Moravek Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 139. Moravek Latest Developments
Table 140. Ascendia Pharmaceuticals Details, Company Type, Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Area Served and Its Competitors
Table 141. Ascendia Pharmaceuticals Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product Offered
Table 142. Ascendia Pharmaceuticals Main Business
Table 143. Ascendia Pharmaceuticals Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 144. Ascendia Pharmaceuticals Latest Developments
Table 145. Ardena Details, Company Type, Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Area Served and Its Competitors
Table 146. Ardena Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product Offered
Table 147. Ardena Main Business
Table 148. Ardena Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 149. Ardena Latest Developments
Table 150. CPL Details, Company Type, Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Area Served and Its Competitors
Table 151. CPL Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product Offered
Table 152. CPL Main Business
Table 153. CPL Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 154. CPL Latest Developments
Table 155. Arranta Bio Details, Company Type, Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Area Served and Its Competitors
Table 156. Arranta Bio Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product Offered
Table 157. Arranta Bio Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 158. Arranta Bio Main Business
Table 159. Arranta Bio Latest Developments
Table 160. UPM Pharmaceuticals Details, Company Type, Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Area Served and Its Competitors
Table 161. UPM Pharmaceuticals Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product Offered
Table 162. UPM Pharmaceuticals Main Business
Table 163. UPM Pharmaceuticals Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 164. UPM Pharmaceuticals Latest Developments
Table 165. FUJIFILM Diosynth Biotechnologies Details, Company Type, Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Area Served and Its Competitors
Table 166. FUJIFILM Diosynth Biotechnologies Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product Offered
Table 167. FUJIFILM Diosynth Biotechnologies Main Business
Table 168. FUJIFILM Diosynth Biotechnologies Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 169. FUJIFILM Diosynth Biotechnologies Latest Developments
Table 170. Groupe Parima Details, Company Type, Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Area Served and Its Competitors
Table 171. Groupe Parima Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product Offered
Table 172. Groupe Parima Main Business
Table 173. Groupe Parima Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 174. Groupe Parima Latest Developments
Table 175. TBD Pharmatech Details, Company Type, Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Area Served and Its Competitors
Table 176. TBD Pharmatech Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product Offered
Table 177. TBD Pharmatech Main Business
Table 178. TBD Pharmatech Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 179. TBD Pharmatech Latest Developments
Table 180. Avid Bioservices Details, Company Type, Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Area Served and Its Competitors
Table 181. Avid Bioservices Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product Offered
Table 182. Avid Bioservices Main Business
Table 183. Avid Bioservices Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 184. Avid Bioservices Latest Developments
Table 185. Vetter Pharma Details, Company Type, Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Area Served and Its Competitors
Table 186. Vetter Pharma Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product Offered
Table 187. Vetter Pharma Main Business
Table 188. Vetter Pharma Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 189. Vetter Pharma Latest Developments
Table 190. NextPharma Details, Company Type, Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Area Served and Its Competitors
Table 191. NextPharma Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product Offered
Table 192. NextPharma Main Business
Table 193. NextPharma Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 194. NextPharma Latest Developments
Table 195. Alcami Details, Company Type, Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Area Served and Its Competitors
Table 196. Alcami Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product Offered
Table 197. Alcami Main Business
Table 198. Alcami Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 199. Alcami Latest Developments
Table 200. NerPharMa Details, Company Type, Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Area Served and Its Competitors
Table 201. NerPharMa Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product Offered
Table 202. NerPharMa Main Business
Table 203. NerPharMa Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 204. NerPharMa Latest Developments
Table 205. Vetio Details, Company Type, Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Area Served and Its Competitors
Table 206. Vetio Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product Offered
Table 207. Vetio Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 208. Vetio Main Business
Table 209. Vetio Latest Developments
Table 210. Societal CDMO Details, Company Type, Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Area Served and Its Competitors
Table 211. Societal CDMO Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product Offered
Table 212. Societal CDMO Main Business
Table 213. Societal CDMO Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 214. Societal CDMO Latest Developments
Table 215. ten23 health Details, Company Type, Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Area Served and Its Competitors
Table 216. ten23 health Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product Offered
Table 217. ten23 health Main Business
Table 218. ten23 health Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 219. ten23 health Latest Developments
Table 220. Piramal Pharma Solutions Details, Company Type, Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Area Served and Its Competitors
Table 221. Piramal Pharma Solutions Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product Offered
Table 222. Piramal Pharma Solutions Main Business
Table 223. Piramal Pharma Solutions Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 224. Piramal Pharma Solutions Latest Developments
Table 225. MedPharm Details, Company Type, Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Area Served and Its Competitors
Table 226. MedPharm Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product Offered
Table 227. MedPharm Main Business
Table 228. MedPharm Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 229. MedPharm Latest Developments
Table 230. Lundbeck Details, Company Type, Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Area Served and Its Competitors
Table 231. Lundbeck Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product Offered
Table 232. Lundbeck Main Business
Table 233. Lundbeck Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 234. Lundbeck Latest Developments
Table 235. AGC Pharma Chemicals Details, Company Type, Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Area Served and Its Competitors
Table 236. AGC Pharma Chemicals Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product Offered
Table 237. AGC Pharma Chemicals Main Business
Table 238. AGC Pharma Chemicals Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 239. AGC Pharma Chemicals Latest Developments
Table 240. BioVectra Details, Company Type, Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Area Served and Its Competitors
Table 241. BioVectra Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product Offered
Table 242. BioVectra Main Business
Table 243. BioVectra Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 244. BioVectra Latest Developments
Table 245. Pfizer CentreOne Details, Company Type, Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Area Served and Its Competitors
Table 246. Jubilant Biosys Details, Company Type, Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Area Served and Its Competitors
Table 247. SEIKAGAKU CORPORATION Details, Company Type, Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Area Served and Its Competitors
Table 248. Mikart Details, Company Type, Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Area Served and Its Competitors
Table 249. Adare Pharma Solutions Details, Company Type, Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Area Served and Its Competitors
Table 250. Fermion Details, Company Type, Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Area Served and Its Competitors
Table 251. Samsung Biologics Details, Company Type, Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Area Served and Its Competitors
Table 252. Siegfried Holdings Details, Company Type, Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Area Served and Its Competitors
Table 253. Boehringer Ingelheim Details, Company Type, Pharmaceutical CDMO (Pharmaceutical Contract Development an


More Publications